UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

A recent publication from IMDEA Materials Institute and the Technical University of Madrid (UPM) presents a major step ...

Scientists in the US have been testing spin-polarized nuclear fuel inside tokamaks operating at ...

Industrial copilot, powered by Azure AI, cuts engineering time by up to 50% with production changes that once took weeks now ...

Our vision for the School is to be a global leader empowering individuals, organisations and societies to critically understand and inform a rapidly changing information, journalism and communication ...

This is called electromagnetic induction close electromagnetic inductionThe production of a potential difference (voltage) when a conductor, such as a wire, is moved through a magnetic field or ...